Clinical and Applied Thrombosis/Hemostasis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to start reading!

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, W.-H.
Right arrow Articles by Liu, J.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, W.-H.
Right arrow Articles by Liu, J.-S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical and Applied Thrombosis/Hemostasis, Vol. 9, No. 2, 155-162 (2003)
DOI: 10.1177/107602960300900211

The Prevalence of Protein C, Protein S, and Antithrombin III Deficiency in non-APS/SLE Chinese Adults with Noncardiac Cerebral Ischemia

Wei-Hsi Chen

Min-Yu Lan

Yung-Yee Chang

Shun-Sheng Chen

Jia-Shou Liu

Stroke Biology Research Laboratory, Department of Neurology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan

Protein C (PC), protein S (PS), and antithrombin III (AT-III) are vital thrombin antagonists in circulation. However, the prevalence of these natural inhibitors for cerebral ischemia is barely mentioned in the Chinese population. The prevalence of PC, PS, and AT-III deficiency in Chinese adults with cerebral ischemia is reported. The study subjects were free of antiphospholipid antibody syndrome or systemic lupus erythrematosus. Cardiac, liver, and renal function were normal. An overall rate of thrombophilia was 27%. PS deficiency was the most common disorder, followed by PC with PS and PC deficiency. There was only one patient with AT-Ill deficiency. No gender was specific for thrombophilia. However, PS deficiency was predilected in young adults. A positive correlation between PC and AT-III was achieved in patients with a normal PC activity but not PC deficiency. There was no correlation between AT-III or PS. The odds ratios of PC and PS were 5.29 and 2.86, respectively. Accordingly, an inability for thrombin antagonization by the PC/PS axis may relate to the occurrence of cerebral ischemia in the Chinese population. AT-III seems to display a minor role only.

Key Words: Protein C • Protein S • Antithrombin III • Cerebral ischemia • Chinese


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
Wei Hsi Chen, Hung Sheng Lin, Yi Fen Kao, Min Yu Lan, and Jia Shou Liu
Hyperhomocysteinemia Relates to the Subtype of Antiphospholipid Antibodies in Non-SLE Patients
Clinical and Applied Thrombosis/Hemostasis, October 1, 2007; 13(4): 398 - 403.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W.-H. Chen, C.-C. Lui, C.-J. Chen, and J.-S. Liu
An Increase of Anticardiolipin Antibody in Association with Stroke and Chronic Chemical Exposure
Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 231 - 235.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. H. Chen, Y.-F. Kao, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu
The Increase of Blood Anticardiolipin Antibody Depends on the Underlying Etiology in Cerebral Ischemia
Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 69 - 76.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. H. Chen, Y.-F. Kao, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu
The Increase of Blood Anticardiolipin Antibody Depends on the Underlying Etiology in Cerebral Ischemia
Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 203 - 210.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. H. Chen
Anti-beta2-Glycoprotein I Antibody and Hypertension in Cerebral Ischemia
Clinical and Applied Thrombosis/Hemostasis, January 1, 2004; 10(1): 55 - 60.
[Abstract] [PDF]